Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy

作者：Daniela Estefania Banegas, Isacco Ferrarini, Andrea Bernardelli, Alessia Moioli, Vittorio Ruggero Zilioli, Luca Nassi, Chiara Rusconi, Beatrice Casadei, Cinzia Pellegrini, Guido Gini, Giuseppe Gritti, Giulia Daghia, Elsa Pennese, Luigi Petrucci, Simone Ferrero, Sonya De Lorenzo, Sara Veronica Usai, Ausilia Gorgone, Massimo Gentile, Alessia Castellino, Anna Vanazzi, Luigi Curreli, Lucia Morello, Monica Tani, Daniela Renzi, Brunella Mola, Alberto Fabbri, A. Molteni, Roberta Sciarra, Pier Luigi Zinzani, C. Visco · 发表于：Leukemia & lymphoma/Leukemia and lymphoma · 年份：2026 · DOI：10.1080/10428194.2026.2621825 · 被引用次数：2 · 研究领域：Chronic Lymphocytic Leukemia Research、Lymphoma Diagnosis and Treatment、Cutaneous lymphoproliferative disorders research

MCL is a rare subtype of B-cell non-Hodgkin lymphoma, accounting for approximately 5–7% of all lymphomas and showing a higher prevalence in males. MCL is characterized by the expression of CD5 and ...